EMJ Podcast: Insights For Healthcare Professionals

Stephanie Rutledge joins host Saranya Ravindran to unpack the mental health dimensions of alcohol use disorder. From co-occurring conditions and behavioural strategies like motivational interviewing to the role of family and community support, this episode explores how integrated care can strengthen recovery.

Timestamps:

1:44 – Why hepatology

3:25 – Genetic factors

4:18 – Alcohol use disorder interventions

5:58 – Motivational interviewing

7:25 – Motivational interviewing skills

8:34 – Beyond clinical settings

10:49 – Alcohol use disorder therapy

In this rapid-fire episode, Stephanie Rutledge answers key questions on alcohol in hepatology, from mental health challenges in alcohol use disorder to transplant misconceptions, emerging therapies, and the impact of lifestyle changes like Dry January. It provides a concise, insightful overview in just minutes.

Timestamps:

1:08 – Treating alcohol use disorder

1:33 – Technique for alcohol use disorder recovery

1:50 – Misconceptions

2:14 – Psychosocial factors

2:32 – Alcohol use disorder and liver transplantation

2:50 – Experimental education

3:09 – Dry January and sober October

3:35 – Mental health

3:53 – Halting disease progression

4:14 – Liver transplantation

4:46 – Breakthrough therapies

This podcast and accompanying promotional content has been created in collaboration with and funded by Biogen. This information is intended for healthcare professionals. The presented content includes mentions of the Skyclarys▼ (omaveloxolone) EU-approved label.

Prescribing information for omaveloxolone can be found here.

Friedreich's ataxia (FA) is a rare genetic disease that can affect children and adults and cause progressive neurodegeneration, loss of physical function, multiple comorbidities, and even premature death.

In this episode, two well renowned experts, Dr Louise Corben and Dr Wolfgang Nachbauer discuss the diagnostic journey for patients with FA, disease progression and the importance of working with multidisciplinary teams in the development of management strategies.

In the final episode, Debby Bogaert discusses how cutting-edge microbiome science is being translated into practice. From novel vaccine approaches to strategies that support the developing microbiome, this conversation highlights how research can drive new preventive solutions to reduce pneumococcal disease and promote healthier lives for children everywhere.

0:30- Mucosal Vaccines

2:02 - Rotavirus Vaccine

2:49- Microbiome Science Policy

4:22- Ethics in Infant Microbiome

6:35- Final Message

In part two, Debby Bogaert unpacks her pioneering research on the infant respiratory microbiome. Discover how early microbial communities in the airways influence immunity, infection risk, and long-term respiratory health — and why nurturing the microbiome could play a critical role in disease prevention.

0:38- Microbiome and Resilience Against Infection

1:57- Microbiome in Healthy Infancy

3:00- Respiratory Microbiome and Inflammation

4:31- Benefits of Commensal Bacteria

6:39- Microbiome-Based Diagnostics

7:55- Pre and Post Biotics

10:03- Day-to-Day Practice

In this episode, host Jonathan Sackier is joined by Andrew Dunbar, Assistant Professor in the Department of Hematopoietic Biology and Malignancy at the University of Texas MD Anderson Cancer Center, Houston, USA. Dunbar discusses his research into myeloproliferative neoplasms, what drives disease progression and resistance, and promising targets for treatment, while reflecting on the mission of his lab and what lies ahead for the field.

Timestamps

00:00 – Introduction

02:29 – One thing people should know about myeloproliferative neoplasms

05:01 – Dunbar's background and research focus

08:00 – What would Dunbar do if not science and medicine?

10:24 – The basics of myeloproliferative neoplasms

14:30 – Myeloproliferative neoplasm diagnosis and treatment

16:49 – What drives disease progression and resistance?

18:30 – The mission of Dunbar's lab

21:23 – Development of AJ1-11095

22:54 – Balancing the complexity of disease modelling with urgent clinical needs

24:03 – Promising targets and pathways

26:35 – What's on the horizon?

28:40 – Three wishes

In this first deep dive, Debby Bogaert explores the global burden of pneumococcal disease in young children and compares its impact with RSV and flu. She discusses how pneumococcus colonises the respiratory tract, the role of co-infections, and the importance of vaccination. Listeners will also learn how early life factors and microbiome recovery shape the infant respiratory ecosystem.

Timestamps:

0:42- Pneumococcus in Young Children 2:46- Global Burden of Pneumococcal Disease 4:15- Pneumococcus vs RSV and Flu 7:17- Microbiome Recovery 8:29- Pneumococcal Vaccination 9:46- Role of Co-Infections 11:34- Colonisation 13:30- Respiratory Tract As an Ecosystem 15:44- Early Life Factors

Get to know Debby Bogaert in this fast-paced quickfire round. She shares the most overlooked aspect of pneumococcal disease, clears up common misconceptions, and reveals the biggest surprise from her research. From advice for new parents to public health leaders, this bite-sized episode is packed with insights

Timestamps:

2:14- Overlooked aspect of pneumococcal disease

2:37- Infant Microbiome

2:50- One Misconception

3:04- Biggest Surprise

3:26- Message to New Parents

3:54- Advice to Public Health Leaders

In this episode, host Saranya Ravindran is joined by Toby Maher to explore the often-overlooked world of interstitial lung diseases. From clarifying common misconceptions to highlighting AI innovations and personalised treatments, the series dives deep into what clinicians need to know about these serious lung conditions. Whether you're new to interstitial lung diseases or experienced in respiratory care, this series offers timely insights and expert takeaways.

Timestamps:

00:00: Introduction

00:40: Mainstays of treatment

04:42: Limitations of current antifibrotics

07:50: The future of ILD personalised care

13:40: Are we close to the reversal of fibrosis?

15:52: A message for clinicians

In this episode, host Saranya Ravindran is joined by Toby Maher to explore the often-overlooked world of interstitial lung diseases. From clarifying common misconceptions to highlighting AI innovations and personalised treatments, the series dives deep into what clinicians need to know about these serious lung conditions. Whether you're new to interstitial lung diseases or experienced in respiratory care, this series offers timely insights and expert takeaways.

Timestamps:

00:00: Introduction

00:41: Challenges in early diagnosis

03:22: ILD biomarkers

05:49: The overlap with autoimmune diseases

09:16: AI in ILD detection